US30234E1047 - EYEN (XNAS)
EYENOVIA INC Aktie
0,50 USD
Aktuelle Kurse von EYENOVIA INC
Börse | Ticker | Währung | Letzter Umsatz | Kurs | Tagesveränderung | Tagesveränderung % |
---|---|---|---|---|---|---|
NASDAQ |
EYEN
|
USD
|
20.09.2024 14:48
|
0,50 USD
| 0,51 USD | -1,43 % |
Performance
Tag | Woche | Monat | 3 Monate | 6 Monate | 1 Jahr | 5 Jahre |
---|---|---|---|---|---|---|
-3,19 % | -9,93 % | -38,94 % | -20,51 % | -57,34 % | -70,21 % | -89,58 % |
Firmenprofil zu EYENOVIA INC Aktie
Eyenovia, Inc., a clinical stage ophthalmic company, engages in developing therapeutics based on its proprietary microdose array print platform technology. The company focuses on developing clinical microdosing of formulations of ophthalmic pharmaceutical agents using its Optejet branded targeted ocular delivery system. It focuses on the development of therapeutic indications for patients with progressive myopia and age-related near vision impairment or presbyopia indications; and microdose fixed combination ophthalmic pharmaceutical for mydriasis to address the eye exams with pupil dilation. The company's product candidates include MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); and MydCombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; and a license agreement with Arctic Vision (Hong Kong) Limited to develop and commercialize MicroPine and MicroLine in China and South Korea. The company was formerly known as PGP Holdings V, Inc. and changed its name to Eyenovia, Inc. in May 2014. Eyenovia, Inc. was incorporated in 2014 and is headquartered in New York, New York.
Unternehmensdaten zur EYENOVIA INC Aktie
Name EYENOVIA INC
Firma Eyenovia, Inc.
Symbol EYEN
Website https://www.eyenovia.com
Heimatbörse
NASDAQ
ISIN US30234E1047
Wertpapierart Aktie
Sektor Healthcare
Branche Biotechnology
CEO Mr. Michael M. Rowe
Marktkapitalisierung 38 Mio
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 0,1 T
Adresse 295 Madison Avenue, 10017 New York
IPO Datum 2018-01-25
Ticker Symbole
Name | Symbol |
---|---|
NASDAQ | EYEN |
Weitere Aktien
Investoren die EYENOVIA INC halten haben auch folgende Aktien im Depot:
Die Finanzplattform goSPATZ trackt und analysiert Investitionen und Portfolios.
Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
All rights reserved © LCP GmbH 2024